Digital platform improves type 2 diabetes control and may cut NHS costs

A University of Manchester study has found that the NHS‑supported digital platform MyWay Diabetes improves blood‑sugar control and overall health for people with type 2 diabetes, with the potential to reduce long‑term NHS costs. The research, published this week, analysed data from users across Greater Manchester who accessed the platform during the COVID‑19 pandemic.

MyWay Diabetes is an online portal and mobile app that allows patients to view their diabetes health records, track glucose readings and other metrics, and complete short educational courses and receive tailored advice. The study reported statistically significant reductions in HbA1c levels and a lower incidence of diabetes‑related complications among platform users compared with a matched control group. Researchers also noted that the improved glycaemic control could translate into measurable savings for the National Health Service over the coming years.

The findings support the continued expansion of digital health interventions for chronic disease management. By providing patients with real‑time access to their data and educational resources, MyWay Diabetes demonstrates how technology can enhance self‑management and potentially ease the financial burden on the NHS.